Day

February 20, 2019
We will be joining an exciting ensemble of Danish biotech companies travelling to New York to present Insusense’s technology!
Read More

About Us

InsuSence Therapeutics is a product-focused biotechnology company based on novel breakthrough science in diabetes biology, which has the potential to quantum leap to important new Type 2 diabetes therapeutics.